Abstract
THE alkylating agent, N,N-bis-(β-chlorethyl)-N′, O-propylenephosphoric acid ester diamide1 (B-518, cyclophosphamide, ‘Endoxan’, ‘Cytoxan’), has been markedly effective in suppressing the growth of a variety of transplanted tumours in rats2,3 and mice3. The mechanism of activation of this agent has not been determined. It is known that the drug is not cytotoxic in vitro, but is activated in vivo 4. Nicotinamide has been reported to prevent the toxic and antitumour effects of ‘Cytoxan’5. However, the relationship of nicotinamide or diphosphopyridine nucleotide to either the activation or the action of this alkylating agent is unknown. Resistant tumours have proved valuable for the study of the mechanism of action of chemotherapeutic compounds. Sublines resistant to alkylating agents and derived from previously sensitive tumours are uncommon and have not been investigated extensively. It was thought that if a tumour resistant to ‘Cytoxan’ could be developed, it might provide a useful model for the study of the action of this alkylating agent.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arnold, H., and Bourseaux, F., Angew. Chemie, 70, 539 (1958).
Brock, N., and Wilmanns, H., Deut. med. Wchnschr., 83, 453 (1958).
Lane, M., and Kelly, M. G., Proc. Amer. Assoc. Cancer Res., 3, 35 (1959).
Arnold, H., Bourseaux, F., and Brock, N., Naturwiss., 45, 64 (1958). Burchenal, J. H., Oettgen, H. F., Reppert, J. A., and Coley, V., Proc. Amer. Assoc. Cancer Res., 3, 99 (1960). Foley, G. E., Friedman, O. M., and Drolet, B. P., ibid, 3, 111 (1960). Wight, K., Burk, D., Woods, M., and Lane, M., ibid., 3, 162 (1960).
Holzer, H., and Kröger, H., Klin. Wchnschr., 36, 677 (1958).
Lane, M., Fed. Proc., 18, 413 (1959).
Lane, M., J. Nat. Cancer Inst., 23, 1347 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LANE, M., YANCEY, S. Development of a Leukæmia resistant to Cyclophosphamide (‘Cytoxan’). Nature 188, 756–757 (1960). https://doi.org/10.1038/188756a0
Issue Date:
DOI: https://doi.org/10.1038/188756a0
This article is cited by
-
Sustained drug resistance of a transplantable strain of rat leukemia (erythromyelosis) to paraphenacyl
Bulletin of Experimental Biology and Medicine (1968)
-
Kreuzresistenzuntersuchungen an, degranolresistenten NK/ly-Ascites-Tumoren
Zeitschrift f�r Krebsforschung (1966)
-
�ber die morphologische Wirkung verschiedener Chemotherupeutica auf Degranol-empfindlichen und Degranol-resistenten NK/Ly Ascites-Tumor
Zeitschrift f�r Krebsforschung (1965)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
